Transcriptomics

Dataset Information

0

Sodium oligomannate disrupts the adherence of Ribhigh bacteria to gut epithelia to block SAA-triggered Th1 inflammation in 5XFAD transgenic mouse


ABSTRACT: Sodium oligomannate (GV-971), an oligosaccharide drug approved in China for treating mild-to-moderate Alzheimer's disease (AD), was previously found to recondition the gut microbiota and limit altered peripheral Th1 immunity in AD transgenic mice. As a follow-up study, we here provide advances by pinpointing a Lactobacillus murinus strain that highly expressed a gene encoding a putative adhesin containing Rib repeats (Ribhigh-L.m.) that was particularly enriched in 5XFAD transgenic mice. Mechanistically, Ribhigh-L.m. adherence to the gut epithelia upregulated fecal metabolites, among which lactate ranked as the top candidate. Lactate stimulated the epithelial production of serum amyloid A (SAA) in gut via GPR81-NFκB axis, contributing to peripheral Th1 activation. Moreover, GV-971 disrupted the adherence of Ribhigh-L.m. to gut epithelia via directly binding to Rib, leading to the reduced SAA and alleviated Th1-skewed inflammation. These findings were replicated in early-staged AD patients. Together, we gained further insights between gut bacteria and AD progression and the mechanism of GV-971 in treating AD.

ORGANISM(S): Ligilactobacillus murinus

PROVIDER: GSE247212 | GEO | 2024/11/20

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2024-07-04 | GSE271034 | GEO
2018-03-12 | MTBLS539 | MetaboLights
2021-01-20 | GSE158152 | GEO
| PRJNA1129455 | ENA
2021-08-04 | PXD027692 | JPOST Repository
2011-08-16 | E-GEOD-31424 | biostudies-arrayexpress
2023-07-19 | GSE237388 | GEO
2015-12-21 | GSE73780 | GEO
2015-12-21 | GSE72598 | GEO
2021-03-26 | GSE156528 | GEO